<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-1146</journal-id>
<journal-title><![CDATA[Boletín médico del Hospital Infantil de México]]></journal-title>
<abbrev-journal-title><![CDATA[Bol. Med. Hosp. Infant. Mex.]]></abbrev-journal-title>
<issn>1665-1146</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-11462015000500299</article-id>
<article-id pub-id-type="doi">10.1016/j.bmhimx.2015.09.001</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Retinoblastoma in Mexico: part I. A review of general knowledge of the disease, diagnosis, and management]]></article-title>
<article-title xml:lang="es"><![CDATA[Retinoblastoma en México: parte I. Revisión del conocimiento general de la enfermedad, diagnóstico y tratamiento]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lansingh]]></surname>
<given-names><![CDATA[Van C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Eckert]]></surname>
<given-names><![CDATA[Kristen A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Haik]]></surname>
<given-names><![CDATA[Barrett G.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Phillipps]]></surname>
<given-names><![CDATA[Blanca X.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bosch-Canto]]></surname>
<given-names><![CDATA[Vanessa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Leal-Leal]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez-Ortiz]]></surname>
<given-names><![CDATA[Marco A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano de Oftalmología  ]]></institution>
<addr-line><![CDATA[Querétaro Querétaro]]></addr-line>
<country>MX</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Help Me See  ]]></institution>
<addr-line><![CDATA[New York NY]]></addr-line>
<country>US</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,The University of Tennessee Health Science Center Hamilton Eye Institute Department of Ophthalmology]]></institution>
<addr-line><![CDATA[Memphis TN]]></addr-line>
<country>US</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Independent Public Health Consultant  ]]></institution>
<addr-line><![CDATA[Tapachula Chiapas]]></addr-line>
<country>MX</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Nacional de Pediatría  ]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>MX</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez Department of Ophthalmology ]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>MX</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>72</volume>
<numero>5</numero>
<fpage>299</fpage>
<lpage>306</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-11462015000500299&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-11462015000500299&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-11462015000500299&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[AbstractThis is the first of a two-part review that aims to report the current knowledge of retinoblastoma (Rb) and its implications in Mexico (including the authors' experience at the leading Rb centers), identify the gaps in practice, and propose solutions to improve diagnosis, treatment, and patient uptake. In this first part, general knowledge of Rb diagnosis and management is summarized with a focus on the latest advances in chemotherapy. A general review of peer-reviewed literature of Rb was conducted on PubMed. Key findings were summarized.Provided there is early detection and referral of patients followed by appropriate conservative management, Rb is curable. In developed countries, the primary treatment outcome is ocular salvage with sight preservation. Advanced chemotherapeutic options such as intra-arterial and intravitreal chemotherapy can now save even the most advanced tumors.Advances in Rb therapy are generally limited to developed countries. The implications in Mexico, of the findings from this review will be discussed in Part 2, which will be a comprehensive situational analysis of the state of Rb programming in Mexico, including a review of current demographic data available from hospitals that have Rb programs or treat Rb.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[ResumenEsta es la primera parte de un trabajo de revisión donde se reportan los conocimientos actuales del retinoblastoma (Rb) y sus implicaciones en México (incluyendo la experiencia de los autores en los principales centros de referencia), así como las brechas en la práctica y las posibles soluciones para mejorar el diagnóstico, tratamiento y referencia de pacientes. En esta parte se resumen los conocimientos generales del Rb, su diagnóstico y tratamiento. Se realizó una revisión de los avances más recientes en esta enfermedad publicados en PubMed y se resumieron los hallazgos más importantes.La sospecha oportuna y la referencia adecuada de pacientes permiten que el tratamiento conservador del Rb sea curativo. En países en vías de desarrollo, el tratamiento primario es el salvamento ocular y la preservación de la visión. Las opciones de quimioterapia intraarterial o intravítrea permiten ofrecer opciones terapéuticas en estos pacientes.Los avances en el tratamiento del Rb están generalmente limitados a países industrializados. Las implicaciones de los hallazgos de esta revisión serán discutidas en la segunda parte, la cual será un análisis de la situación de los programas hospitalarios del Rb en México, incluyendo la revisión de los datos demográficos disponibles de los centros de referencia más importantes.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Retinoblastoma]]></kwd>
<kwd lng="en"><![CDATA[Epidemiology]]></kwd>
<kwd lng="en"><![CDATA[Early cancer detection]]></kwd>
<kwd lng="en"><![CDATA[Disease management]]></kwd>
<kwd lng="es"><![CDATA[Retinoblastoma]]></kwd>
<kwd lng="es"><![CDATA[Epidemiología]]></kwd>
<kwd lng="es"><![CDATA[Diagnóstico temprano del cáncer]]></kwd>
<kwd lng="es"><![CDATA[Manejo de enfermedad]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Developmental basis of retinal-specific induction of cancer by RB mutation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallie]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Devlin]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Duckett]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Squire]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Res.]]></source>
<year>1999</year>
<volume>59</volume>
<numero>^s7</numero>
<issue>^s7</issue>
<supplement>7</supplement>
<page-range>1731S-5S</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma: review of current management]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chintagumpala]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chevez-Barrios]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Paysse]]></surname>
<given-names><![CDATA[E.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Plon]]></surname>
<given-names><![CDATA[S.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hurwitz]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncologist]]></source>
<year>2007</year>
<volume>12</volume>
<page-range>1237-46</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Current update on retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Houston]]></surname>
<given-names><![CDATA[S.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[T.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfe]]></surname>
<given-names><![CDATA[S.Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[C.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int Ophthalmol Clin.]]></source>
<year>2011</year>
<volume>51</volume>
<page-range>77-91</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The incidence of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Devesa]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Ophthalmol.]]></source>
<year>1975</year>
<volume>80</volume>
<page-range>263-5</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Conservative treatment modalities in retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chawla]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Azad]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Indian J Ophthalmol.]]></source>
<year>2013</year>
<volume>61</volume>
<page-range>479-85</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Predicted trends in the incidence of retinoblastoma in the Asia-Pacific Region]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Usmanov]]></surname>
<given-names><![CDATA[R.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kivelä]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Asia Pac J Ophthlamol]]></source>
<year>2014</year>
<volume>3</volume>
<page-range>151-7</page-range><publisher-loc><![CDATA[Phila ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[BD.]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Ophthalmol.]]></source>
<year>2013</year>
<volume>97</volume>
<page-range>1231-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma in Turkey: results from a tertiary care center in Ankara]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gündüz]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Köse]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kurt]]></surname>
<given-names><![CDATA[R.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Süren]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Taçyildiz]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Dinçaslan]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pediatr Ophthalmol Strabismus.]]></source>
<year>2013</year>
<volume>50</volume>
<page-range>296-303</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Outcome of retinoblastoma in east Africa]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bowman]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Mafwiri]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Luthert]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Luande]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Wood]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2008</year>
<volume>50</volume>
<page-range>160-2</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kivelä]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Ophthalmol.]]></source>
<year>2009</year>
<volume>93</volume>
<page-range>1129-31</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A multicentre report from the Mexican Retinoblastoma Group]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leal-Leal]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Flores-Rojo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Medina-Sansón]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cerecedo-Díaz]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Félix]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[González-Ramella]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Ophthalmol.]]></source>
<year>2004</year>
<volume>88</volume>
<page-range>1074-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Development of retinoblastoma programs in Central America]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilimas]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[M.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Haik]]></surname>
<given-names><![CDATA[B.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Barnoya]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2009</year>
<volume>53</volume>
<page-range>42-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Meeting report: Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-PART II]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Howard]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Baez]]></surname>
<given-names><![CDATA[L.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Cabanas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Barrantes]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2007</year>
<volume>48</volume>
<page-range>486-90</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Animal models in retinoblastoma research]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nair]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaliki]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Vemuganti]]></surname>
<given-names><![CDATA[G.K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Saudi J Ophthalmol.]]></source>
<year>2013</year>
<volume>27</volume>
<page-range>141-6</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rushlow]]></surname>
<given-names><![CDATA[D.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Mol]]></surname>
<given-names><![CDATA[B.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kennett]]></surname>
<given-names><![CDATA[J.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Yee]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Pajovic]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Thériault]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Oncol.]]></source>
<year>2013</year>
<volume>14</volume>
<page-range>327-34</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Spectrum of RB1 gene mutations and loss of heterozygosity in Mexican patients with retinoblastoma: identifications of six novel mutations]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macías]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Dean]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Atkinson]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Morales]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[García-Vázquez]]></surname>
<given-names><![CDATA[F.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Saldaña-Álvarez]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Biomark.]]></source>
<year>2008</year>
<volume>4</volume>
<page-range>93-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Anterior diffuse retinoblastoma: mutational analysis and immunofluorescence staining]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crosby]]></surname>
<given-names><![CDATA[M.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Hubbard]]></surname>
<given-names><![CDATA[G.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallie]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Grossniklaus]]></surname>
<given-names><![CDATA[H.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Pathol Lab Med.]]></source>
<year>2009</year>
<volume>133</volume>
<page-range>1215-8</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The genomic landscape of retinoblastoma: a review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thériault]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Dimaras]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallie]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Corson]]></surname>
<given-names><![CDATA[T.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Exp Ophthalmol.]]></source>
<year>2014</year>
<volume>42</volume>
<page-range>33-52</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical misdiagnosis of retinoblastoma in Indian children]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chawla]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Khurana]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Ophthalmol.]]></source>
<year>2014</year>
<volume>98</volume>
<page-range>488-93</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intraocular retinoblastoma: the case for a new group classification]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Linn]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmol Clin North Am.]]></source>
<year>2005</year>
<volume>18</volume>
<page-range>41-53</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Basic understanding of current classification and management of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Opin Ophthalmol.]]></source>
<year>2006</year>
<volume>17</volume>
<page-range>228-34</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[The International Classification of Retinoblastoma is practical and predictable]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Year Book of Ophthalmology]]></source>
<year>2008</year>
<page-range>227-30</page-range><publisher-name><![CDATA[Mosby]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chantada]]></surname>
<given-names><![CDATA[G.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Sampor]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bosaleh]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Solernou]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandiño]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[de Dávila]]></surname>
<given-names><![CDATA[M.T.]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA Ophthalmol.]]></source>
<year>2013</year>
<volume>131</volume>
<page-range>1127-34</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Frontiers in the management of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Ophthalmol.]]></source>
<year>2009</year>
<volume>148</volume>
<page-range>192-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Thermotherapy for retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Diniz]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Gündüz]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Mercado]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Cater]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>1999</year>
<volume>117</volume>
<page-range>885-93</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cryotherapy for retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abramson]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Ellsworth]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rozakis]]></surname>
<given-names><![CDATA[G.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>1982</year>
<volume>100</volume>
<page-range>1253-6</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of cryotherapy in the management of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Giblin]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Ophthalmol.]]></source>
<year>1989</year>
<volume>108</volume>
<page-range>260-4</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of photocoagulation in the management of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Giblin]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>1990</year>
<volume>108</volume>
<page-range>205-8</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The expanding role of laser photocoagulation for intraocular tumors. The 1993 H. Christian Zweng Memorial Lecture]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Retina]]></source>
<year>1994</year>
<volume>14</volume>
<page-range>310-22</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kiratli]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[De Potter]]></surname>
<given-names><![CDATA[P.V.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pediatr Ophthalmol Strabismus]]></source>
<year>1995</year>
<volume>32</volume>
<page-range>317-22</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Episcleral plaque brachytherapy for retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merchant]]></surname>
<given-names><![CDATA[T.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gould]]></surname>
<given-names><![CDATA[C.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[M.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Hilton]]></surname>
<given-names><![CDATA[N.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Galindo]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Haik]]></surname>
<given-names><![CDATA[B.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2004</year>
<volume>43</volume>
<page-range>134-9</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[De Potter]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Minelli]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Brady]]></surname>
<given-names><![CDATA[L.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>1993</year>
<page-range>216-24</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Conservative treatment of retinoblastoma. The use of plaque brachytherapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Brady]]></surname>
<given-names><![CDATA[L.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[De Potter]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Clin Oncol.]]></source>
<year>1993</year>
<volume>16</volume>
<page-range>397-401</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cater]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Othmane]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[A.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Micaily]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2001</year>
<volume>108</volume>
<page-range>2116-21</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mulvihill]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Budning]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jay]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Vandenhoven]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Heon]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallie]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>2003</year>
<volume>121</volume>
<page-range>1120-4</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schmack]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Hubbard]]></surname>
<given-names><![CDATA[G.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Aaberg]]></surname>
<given-names><![CDATA[TM Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Grossniklaus]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Ophthalmol.]]></source>
<year>2006</year>
<volume>142</volume>
<page-range>310-5</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kiratli]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kocabeyo&#287;lu]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bilgiç]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[J AAPOS.]]></source>
<year>2007</year>
<volume>11</volume>
<page-range>404-5</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Opin Ophthalmol.]]></source>
<year>2010</year>
<volume>21</volume>
<page-range>203-12</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[High-risk retinoblastoma based on International Classification of Retinoblastoma: analysis of 519 enucleated eyes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaliki]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rojanaporn]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Dahmash]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[McLaughlin]]></surname>
<given-names><![CDATA[J.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2013</year>
<volume>120</volume>
<page-range>997-1003</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma: recent update and management frontiers]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manjandavida]]></surname>
<given-names><![CDATA[F.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Honovar]]></surname>
<given-names><![CDATA[S.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Ophthalmol.]]></source>
<year>2013</year>
<volume>2</volume>
<page-range>351-3</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Fulco]]></surname>
<given-names><![CDATA[E.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[J.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Alarcon]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Pellegrini]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rishi]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eye]]></source>
<year>2012</year>
<volume>27</volume>
<page-range>253-64</page-range><publisher-loc><![CDATA[Lond ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A new era for the treatment of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferris]]></surname>
<given-names><![CDATA[F.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Chew]]></surname>
<given-names><![CDATA[E.Y.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>1996</year>
<volume>114</volume>
<page-range>1412</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abramson]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Dunkel]]></surname>
<given-names><![CDATA[I.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Brodie]]></surname>
<given-names><![CDATA[S.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Gobin]]></surname>
<given-names><![CDATA[Y.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2008</year>
<volume>115</volume>
<page-range>1398-404</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[M.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Haik]]></surname>
<given-names><![CDATA[B.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Billups]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez-Galindo]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2007</year>
<volume>114</volume>
<page-range>2077-82</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartuma]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Pal]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Kosek]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Holm]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[All-Ericsson]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Ophthalmol.]]></source>
<year>2014</year>
<volume>92</volume>
<page-range>404-11</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kingston]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hungerford]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Madreperla]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Plowman]]></surname>
<given-names><![CDATA[P.N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>1996</year>
<volume>114</volume>
<page-range>1339-43</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Strategies to manage retinoblastoma in developing countries]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chantada]]></surname>
<given-names><![CDATA[G.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Qaddoumi]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Cantruk]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Khetan]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Kimani]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2011</year>
<volume>56</volume>
<page-range>341-8</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intravitreal chemotherapy for vitreous seeding in retinoblastoma, Recent advances and perspectives]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munier]]></surname>
<given-names><![CDATA[F.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Gaillard]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Balmer]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Beck-Popovic]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Saudi J Ophthalmol.]]></source>
<year>2013</year>
<volume>27</volume>
<page-range>147-50</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamane]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaneko]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mohri]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Clin Oncol.]]></source>
<year>2004</year>
<volume>9</volume>
<page-range>69-73</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Manjandavida]]></surname>
<given-names><![CDATA[F.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Arepalli]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaliki]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Lally]]></surname>
<given-names><![CDATA[S.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA Ophthalmol.]]></source>
<year>2014</year>
<volume>132</volume>
<page-range>319-25</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghassemi]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Ophthalmol.]]></source>
<year>2012</year>
<volume>130</volume>
<page-range>1268-71</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abramson]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Dunkel]]></surname>
<given-names><![CDATA[I.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Brodie]]></surname>
<given-names><![CDATA[S.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Marr]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Gobin]]></surname>
<given-names><![CDATA[Y.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2010</year>
<volume>117</volume>
<page-range>1623-9</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Experiment Ophthalmol.]]></source>
<year>2010</year>
<volume>38</volume>
<page-range>638-43</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Local chemotherapeutic agents for the treatment of ocular malignancies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[B.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Nikolitch]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Coates]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Novais]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Odashiro]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Odashiro]]></surname>
<given-names><![CDATA[P.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Surv Ophthalmol.]]></source>
<year>2014</year>
<volume>59</volume>
<page-range>97-114</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schaiquevich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Taich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Torbidoni]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ceciliano]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandino]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Invest Ophthalmol Vis Sci.]]></source>
<year>2012</year>
<volume>53</volume>
<page-range>4205-12</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Ceciliano]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Sampor]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandino]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Villasante]]></surname>
<given-names><![CDATA[F.,]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2014</year>
<volume>121</volume>
<page-range>889-97</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schaiquevich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Ceciliano]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Millan]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Taich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Villasante]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandino]]></surname>
<given-names><![CDATA[A.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2013</year>
<volume>60</volume>
<page-range>766-70</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacokinetic analysis of topotecan after intra-vitreal injection, Implications for retinoblastoma treatment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Höcht]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Chantada]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandiño]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Navo]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Abramson]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Exp Eye Res.]]></source>
<year>2010</year>
<volume>91</volume>
<page-range>9-14</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Mohney]]></surname>
<given-names><![CDATA[BG.]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Ophthalmol.]]></source>
<year>2014</year>
<volume>98</volume>
<page-range>292-7</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the International Classification of Retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Manjandavida]]></surname>
<given-names><![CDATA[F.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Lally]]></surname>
<given-names><![CDATA[S.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Pieretti]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Arepalli]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Caywood]]></surname>
<given-names><![CDATA[E.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2014</year>
<volume>121</volume>
<page-range>1453-60</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tse]]></surname>
<given-names><![CDATA[B.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Steinle]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Haik]]></surname>
<given-names><![CDATA[B.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[M.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA Ophthalmol.]]></source>
<year>2013</year>
<volume>131</volume>
<page-range>903-11</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grossniklaus]]></surname>
<given-names><![CDATA[H.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Ophthalmol.]]></source>
<year>2014</year>
<volume>158</volume>
<page-range>875-91</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Management and outcome of retinoblastoma with vitreous seeds]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manjandavida]]></surname>
<given-names><![CDATA[F.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Honavar]]></surname>
<given-names><![CDATA[S.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Reddy]]></surname>
<given-names><![CDATA[V.A.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Khanna]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2014</year>
<volume>121</volume>
<page-range>517-24</page-range></nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Francis]]></surname>
<given-names><![CDATA[J.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Schaiquevich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Del Sole]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Croxatto]]></surname>
<given-names><![CDATA[J.O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2014</year>
<page-range>1810-7</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munier]]></surname>
<given-names><![CDATA[F.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Gaillard]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Balmer]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Soliman]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Podilsky]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Moulin]]></surname>
<given-names><![CDATA[A.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Ophthalmol.]]></source>
<year>2012</year>
<volume>96</volume>
<page-range>1078-83</page-range></nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Del]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Torbidoni]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandino]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Asprea]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Croxatto]]></surname>
<given-names><![CDATA[J.O.,]]></given-names>
</name>
</person-group>
<source><![CDATA[Exp Eye Res.]]></source>
<year>2013</year>
<volume>108</volume>
<page-range>103-9</page-range></nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ocular pharmacology of topotecan and its activity in retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schaiquevich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Carcaboso]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Taich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Opezzo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bramuglia]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Retina]]></source>
<year>2014</year>
<volume>34</volume>
<page-range>1719-27</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacokinetics, safety, and efficacy of intravitreal digoxin in preclinical models for retinoblastoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winter]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Buitrago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Mena]]></surname>
<given-names><![CDATA[H.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Del Sole]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Laurent]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Negrotto]]></surname>
<given-names><![CDATA[S.,]]></given-names>
</name>
</person-group>
<source><![CDATA[Invest Ophthalmol Vis Sci.]]></source>
<year>2015</year>
<volume>56</volume>
<page-range>4382-93</page-range></nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[On behalf of the SIOP-PODC Graduated-Intensity Retinoblastoma Guidelines Writing Committee. SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chantada]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Luna-Fineman]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Sitorus]]></surname>
<given-names><![CDATA[R.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kruger]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Israels]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Leal-Leal]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2013</year>
<volume>60</volume>
<page-range>719-27</page-range></nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retinoblastoma: lessons and challenges from developing countries. Ellsworth Lecture 2011]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chantada]]></surname>
<given-names><![CDATA[G.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmic Genet.]]></source>
<year>2011</year>
<volume>32</volume>
<page-range>196-203</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Late diagnosis of retinoblastoma in a developing country]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chantada]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Fandiño]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Manzitti]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Urrutia]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Schvartzman]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Dis Child.]]></source>
<year>1999</year>
<volume>80</volume>
<page-range>171-4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
